1. P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study. (25th January 2019) Authors: Ungaro, R; Fenster, M; Dimopoulos, C; Patel, A; Deepak, P; Syal, G; Yarur, A; Hirten, R; Christophi, G; Khatiwada, A; Lin, B; Colombel, J-F; Ha, C; Weisshof, R; Beniwal-Patel, P; Cohen, B; Pekow, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P407 Real-world safety of tofacitinib in inflammatory bowel diseases: a multi-centre study. (25th January 2019) Authors: Yarur, A; Bixuan, L; Deepak, P; Khatiwada, A; Christophi, G; Ciorba, M; Ungaro, R; Fenster, M; Dimopoulos, C; Syal, G; Hirten, R; Colombel, J-F; Ha, C; Weisshof, R; Pekow, J; Patel, A; Beniwal-Patel, P; Cohen, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Predictive value of topoisomerase IIα immunostaining in urothelial bladder carcinoma. Issue 4 (1st April 2001) Authors: Nakopoulou, L; Zervas, A; Lazaris, A Ch; Constantinides, C; Stravodimos, C; Davaris, P; Dimopoulos, C Journal: Journal of clinical pathology Issue: Volume 54:Issue 4(2001) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗